A detailed history of Camber Capital Management LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Camber Capital Management LP holds 1,150,000 shares of JAZZ stock, worth $140 Million. This represents 4.07% of its overall portfolio holdings.

Number of Shares
1,150,000
Previous 1,150,000 -0.0%
Holding current value
$140 Million
Previous $123 Million 4.38%
% of portfolio
4.07%
Previous 3.4%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $54.7 Million - $63.1 Million
475,000 Added 70.37%
1,150,000 $138 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $77.1 Million - $91.8 Million
675,000 New
675,000 $83 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.